These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38525298)

  • 1. Enumeration and Molecular Characterization of Circulating Tumor Cell Using an Epithelial Cell Adhesion Molecule/Vimentin/Epidermal Growth Factor Receptor Joint Capture System in Lung Cancer.
    Jiang W; Wu J; Lin X; Chen Z; Lin L; Yang J
    Clin Med Insights Oncol; 2024; 18():11795549241231568. PubMed ID: 38525298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorting and gene mutation verification of circulating tumor cells of lung cancer with epidermal growth factor receptor peptide lipid magnetic spheres.
    Wang SG; Zhang B; Li CG; Zhu JQ; Sun BS; Wang CL
    Thorac Cancer; 2020 Oct; 11(10):2887-2895. PubMed ID: 32856417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary Study on Detection of Circulating Tumor Cells in Lung Cancer by EGFR/Vimentin/Folic Acid Magnetic Sphere].
    Li G; Wang Y; Tan G; Liu Y; Xu Z; Feng H; Xing W; Xu Z
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):351-359. PubMed ID: 32336066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma.
    Huang XY; Li F; Li TT; Zhang JT; Shi XJ; Huang XY; Zhou J; Tang ZY; Huang ZL
    J Nanobiotechnology; 2023 Jan; 21(1):25. PubMed ID: 36681851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and Clinical Analysis of EpCAM+/Vimentin+ Circulating Tumor Cells in High-Risk Population and Cancer Patients.
    Huang C; Ding S; Huang C; Pan F; Liu X; Zhang H; Zhou J; Liang X; Wang X; Song P
    Front Oncol; 2021; 11():642971. PubMed ID: 34168982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles.
    Liang N; Liu L; Li P; Xu Y; Hou Y; Peng J; Song Y; Bing Z; Wang Y; Wang Y; Jia Z; Yang X; Li D; Xu H; Yu Q; Li S; Hu Z; Yang Y
    J Thorac Dis; 2020 Aug; 12(8):4262-4273. PubMed ID: 32944338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical verification of vimentin/EpCAM immunolipid magnetic sorting system in monitoring CTCs in arterial and venous blood of advanced tumor.
    Liu Y; Li Q; Chen T; Shen T; Zhang X; Song P; Liu L; Liu J; Jiang T; Liang X
    J Nanobiotechnology; 2021 Jun; 19(1):185. PubMed ID: 34134721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The construction of EpCAM/vimentin-PLGA/lipid immunomagnetic microspheres and the isolation of circulating tumor cells from lung cancer.
    Li G; Wang Y; Tan G
    Int J Clin Exp Pathol; 2018; 11(12):5561-5570. PubMed ID: 31949643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response.
    Satelli A; Brownlee Z; Mitra A; Meng QH; Li S
    Clin Chem; 2015 Jan; 61(1):259-66. PubMed ID: 25336717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
    Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
    BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin.
    Po JW; Roohullah A; Lynch D; DeFazio A; Harrison M; Harnett PR; Kennedy C; de Souza P; Becker TM
    J Circ Biomark; 2018; 7():1849454418782617. PubMed ID: 30013673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective Circulating Tumor Cell Isolation Using Epithelial and Mesenchymal Markers in Prostate and Pancreatic Cancer Patients.
    Cha J; Cho H; Chung JS; Park JS; Han KH
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
    Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
    Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
    Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
    Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistency evaluation of lung adenocarcinoma tissue and circulating tumor cells related gene mutation detection based on multi-site immunomagnetic beads.
    Xue K; Luo B; Li X; Deng W; Zeng C; Zuo C
    J Biomater Appl; 2022 Apr; 36(9):1700-1711. PubMed ID: 35029523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.